Product Launch

Provexis PLC
16 December 2005




                                  PROVEXIS PLC
                         ('Provexis' or the 'Company')

                              UK Launch of Sirco(TM)

Provexis, the nutraceutical company that develops scientifically-proven
functional and medical foods, is delighted to confirm the launch of its
Sirco(TM) heart health juice drink in the UK in January 2006.

The Company has so far secured an initial distribution base with two of the five
largest supermarket retailers in the UK, which for reasons of commercial
confidentiality cannot be named at present. Both retailers will distribute
Sirco(TM) nationally. Within the larger of the two supermarket groups, Sirco(TM)
will be initially available in premier stores which represent, by weighted
distribution, approximately 35 per cent. of their total UK distribution base.
Within the second supermarket chain, Sirco(TM) will be initially available, by
weighted distribution, across 70 per cent. of their total UK distribution base.
Both retailers will stock Sirco(TM) in one litre packs of both flavour variants,
Apple & Blueberry and Orange, and the drink will be located in the chilled fruit
juice section.

The Company is in on-going discussions with a number of other retailers and
hopes to make further distribution announcements in 2006. In addition to the one
litre packs, the Company is also developing a 250ml bottle of Sirco(TM) for
distribution to retailers in mid 2006. This bottle will have an extended shelf
life and is intended to widen the distribution base to include independent
chemists, convenience stores and food service industry channels such as health,
education and travel outlets.

Sirco(TM) is the first heart health product to contain the patented
Fruitflow(TM) technology. Fruitflow(TM) was developed by Provexis in order to
help regular 'healthy' consumers reduce the risk of heart attack and stroke. The
natural bioactive works by reducing blood platelet aggregation ('thinning the
blood'), a significant contributing factor to a thrombosis (internal blood
clot). Sirco(TM) carries the health claim 'Helps to Maintain a Healthy Heart and
Benefits Circulation' and is approved by the leading heart health charity, HEART
UK.

Commenting on the forthcoming launch Dr Stephen Franklin, CEO of Provexis, said:

'This marks a significant milestone for Provexis and we are delighted that we
have secured distribution with two of the largest UK supermarkets. Both
retailers are ideal outlets in terms of the demographics and target market for
this product. We will be investing in media advertising as well as in-store
activity to ensure we maximise this substantial opportunity.

We look forward to growing the retailer base for Sirco(TM) throughout 2006,
whilst in parallel securing licensing arrangements with major international food
partners to integrate the FruitFlow(TM) technology into new food products in
global markets.'

For further information please contact:

Provexis plc
Dr Stephen Franklin                           020 8392 6631

Bell Pottinger Corporate & Financial
Ann-Marie Wilkinson/Emma Kent                 020 7861 3232



                      This information is provided by RNS
            The company news service from the London Stock Exchange